In vitro susceptibility of dermatophytes to oral antifungal drugs and amphotericin B in Uttar Pradesh, India

Background: Dermatophytosis is a major public health problem in our country. Although resistance to conventional oral and topical antifungal agents is being increasingly encountered, the sensitivity pattern of dermatophytes has not been systematically analysed. Aims: We aimed to determine the sensitivity pattern of dermatophyte isolates to amphotericin B and six oral antifungal drugs. Materials and Methods: Patients with dermatophytosis attending the outpatient department of dermatology were enrolled in the study. Samples were collected for mycological examination and in vitro antifungal sensitivity testing was done by broth microdilution as per the Clinical and Laboratory Standard Institute M38-A standards. Results: A total of 804 patients were enrolled. Specimens from 185 patients (23%) were both KOH and culture positive, and 44 of these isolates (41 Trichophyton mentagrophytes and 3 Trichophyton rubrum) were subjected to sensitivity testing. Minimum inhibitory concentrations (MIC) of itraconazole, ketoconazole, voriconazole and amphotericin B were comparable. The median MIC to fluconazole was higher than the other tested drugs. Dermatophytes were most susceptible to ketoconazole and voriconazole, followed by itraconazole, amphotericin B, fluconazole and griseofulvin. A high incidence of resistance was found to terbinafine and the difference was statistically significant in comparison to fluconazole, itraconazole, voriconazole, ketoconazole (P = 0.001) and griseofulvin (P = 0.003). The strains were more sensitive to amphotericin B as compared to griseofulvin (P = 0.02) and terbinafine (P < 0.001). Limitations: This was a hospital-based study and may not reflect the true pattern in the community. Only a few of the isolates were selected for study. The clinical response of patients, whose isolates were studied for in vitro sensitivity of the antifungals, was not studied. Conclusions: The sensitivity pattern of dermatophytes to various antifungals including amphotericin B, ketoconazole, voriconazole and itraconazole were determined. The studied isolates were least susceptible to terbinafine.

[1]  R. Tilak,et al.  Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center , 2017, Indian journal of dermatology, venereology and leprology.

[2]  Lakshmi Vasantha Poluri,et al.  Clinicomycological Study of Dermatophytosis in South India , 2015, Journal of laboratory physicians.

[3]  B. Appalaraju,et al.  Antifungal susceptibility testing for dermatophytes isolated from clinical samples by broth dilution method in a tertiary care hospital , 2015, The Journal of Medical Research.

[4]  S. Seyedmousavi,et al.  Comparison of the In Vitro Activities of Newer Triazoles and Established Antifungal Agents against Trichophyton rubrum , 2015, Antimicrobial Agents and Chemotherapy.

[5]  K. Ferreira-Paim,et al.  Identification and antifungal susceptibility of fungi isolated from dermatomycoses , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  G. Indira.  In Vitro Antifungal Susceptibility Testing of 5 Antifungal Agents against Dermatophytic Species by CLSI (M38-A) Micro Dilution Method , 2014 .

[7]  Y. Bulut,et al.  In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey , 2013, International journal of dermatology.

[8]  S. Hashemi,et al.  In-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran , 2013, Iranian journal of pharmaceutical research : IJPR.

[9]  H. El-Mahallawy,et al.  Public health significance of dermatophytes in Ismailia and Port Said Provinces, Egypt. , 2013, Medical mycology journal.

[10]  Maria R R Silva,et al.  Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  D. Heidrich,et al.  Antifungal susceptibility of dermatophytes isolated from patients with chronic renal failure. , 2011, Anais brasileiros de dermatologia.

[12]  R. Galuppi,et al.  Antimycotic effectiveness against dermatophytes: comparison of two in vitro tests , 2010, Veterinary Research Communications.

[13]  Aditya K. Gupta,et al.  Update in Antifungal Therapy of Dermatophytosis , 2008, Mycopathologia.

[14]  D. A. Santos,et al.  In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole , 2007, Mycoses.

[15]  D. A. Santos,et al.  In vitro methods for antifungal susceptibility testing of Trichophyton spp. , 2006, Mycological research.

[16]  M. Ghannoum,et al.  Voriconazole Susceptibilities of Dermatophyte Isolates Obtained from a Worldwide Tinea Capitis Clinical Trial , 2006, Journal of Clinical Microbiology.

[17]  C. Osborne,et al.  Amino Acid Substitution in Trichophyton rubrum Squalene Epoxidase Associated with Resistance to Terbinafine , 2005, Antimicrobial Agents and Chemotherapy.

[18]  A. Gupta,et al.  In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. , 2005, Medical mycology.

[19]  M. Chadeganipour,et al.  In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan , 2004, Mycoses.

[20]  N. Ryder,et al.  Comparison of In Vitro Activities of 17 Antifungal Drugs against a Panel of 20 Dermatophytes by Using a Microdilution Assay , 2003, Journal of Clinical Microbiology.

[21]  Aditya K. Gupta,et al.  In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity , 2003, The British journal of dermatology.

[22]  M. Ghannoum,et al.  Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to Terbinafine , 2003, Antimicrobial Agents and Chemotherapy.

[23]  J. Guarro,et al.  In Vitro Activities of 10 Antifungal Drugs against 508 Dermatophyte Strains , 2001, Antimicrobial Agents and Chemotherapy.

[24]  W. Meinhof,et al.  Susceptibility of Trichophyton rubrum to griseofulvin , 1991, Mycoses (Berlin).

[25]  K. Lenhart.  Griseofulvin‐resistant Mutants in Dermatophytes 1. The frequency of spontaneous and UV‐induced mutants , 1969, Mykosen.